These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 26184673)
1. Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influences. Montico F; Kido LA; San Martin R; Rowley DR; Cagnon VH Prostate; 2015 Oct; 75(14):1643-61. PubMed ID: 26184673 [TBL] [Abstract][Full Text] [Related]
2. Association of anti-inflammatory and antiangiogenic therapies negatively influences prostate cancer progression in TRAMP mice. Mateus PAM; Kido LA; Silva RS; Cagnon VHA; Montico F Prostate; 2019 Apr; 79(5):515-535. PubMed ID: 30585351 [TBL] [Abstract][Full Text] [Related]
3. Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Montico F; Kido LA; Hetzl AC; Cagnon VH Prostate; 2015 Apr; 75(5):484-99. PubMed ID: 25521760 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic and finasteride therapies: responses of the prostate microenvironment in elderly mice. Kido LA; Hetzl AC; Cândido EM; Montico F; Lorencini RM; Cagnon VH Life Sci; 2014 Jun; 106(1-2):58-70. PubMed ID: 24792519 [TBL] [Abstract][Full Text] [Related]
5. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536 [TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice. Montico F; Kido LA; Hetzl AC; Lorencini RM; Cândido EM; Cagnon VH Histochem Cell Biol; 2014 Sep; 142(3):269-84. PubMed ID: 24562790 [TBL] [Abstract][Full Text] [Related]
7. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910 [TBL] [Abstract][Full Text] [Related]
8. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model. Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058 [TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Yang F; Strand DW; Rowley DR Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743 [TBL] [Abstract][Full Text] [Related]
10. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches. Kido LA; de Almeida Lamas C; Maróstica MR; Cagnon VHA Life Sci; 2019 Jan; 217():141-147. PubMed ID: 30528182 [TBL] [Abstract][Full Text] [Related]